| No (N=7) |
Yes (N=92) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 51.1 (6.18) | 55.4 (10.4) | 0.639 |
| Median [Min, Max] | 50.0 [46.0, 64.0] | 55.0 [24.0, 82.0] | |
| Operation_history | |||
| Direct_surgery | 7 (100%) | 59 (64.1%) | 0.152 |
| Septal_tumor_reduction | 0 (0%) | 1 (1.1%) | |
| Surgery_after_neoadjuvant | 0 (0%) | 32 (34.8%) | |
| Type | |||
| CCC | 0 (0%) | 2 (2.2%) | 0.0549 |
| EC | 1 (14.3%) | 2 (2.2%) | |
| HGSC | 5 (71.4%) | 84 (91.3%) | |
| LGSC | 0 (0%) | 2 (2.2%) | |
| MC | 1 (14.3%) | 1 (1.1%) | |
| Missing | 0 (0%) | 1 (1.1%) | |
| Clinical_stage | |||
| I | 1 (14.3%) | 0 (0%) | 0.00293 |
| II | 1 (14.3%) | 7 (7.6%) | |
| III | 2 (28.6%) | 43 (46.7%) | |
| IV | 3 (42.9%) | 42 (45.7%) | |
| Planting_metastasis | |||
| No | 7 (100%) | 0 (0%) | <0.001 |
| Yes | 0 (0%) | 92 (100%) | |
| Lymph.node_metastasis | |||
| No | 2 (28.6%) | 39 (42.4%) | 0.751 |
| Yes | 5 (71.4%) | 53 (57.6%) | |
| TMB_group | |||
| High | 0 (0%) | 5 (5.4%) | 1 |
| Low | 7 (100%) | 85 (92.4%) | |
| Missing | 0 (0%) | 2 (2.2%) | |
| Relapse_within_6months | |||
| Yes | 1 (14.3%) | 12 (13.0%) | 0.872 |
| No | 5 (71.4%) | 59 (64.1%) | |
| Unknown | 1 (14.3%) | 21 (22.8%) |